BRAWN
Brawn Biotech financials
- Market cap
- ₹6 Cr
Quarterly results
| Line item | Q1 FY23 | Q4 FY23 | Q1 FY24 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| EBITDA | 0 | 0 | -0 |
| Net profit | 0 | 0 | -0 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance +22.6% 1Y
1Y: ₹19.01 on 9 Sept 2025 → ₹23.3. High ₹24.35 (17 Nov 2025), low ₹17.85 (16 Feb 2026).
Balance sheet
| Year ending | FY23 |
|---|
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Jun 2025, promoters trimmed −0.72 pp while the public added +0.72 pp. The shareholder count shrank 17% to 3,284.
- Promoters
- 52.9%
- DIIs
- 0.3%
- Public
- 46.7%
Since Jun 2025
- Promoters −0.72 pp
- Public +0.72 pp
- DIIs 0.00 pp
How it drifted, 12 quarters
Over this window the public went from 45.7% to 46.7% — +1.0 pp.
Ownership split by quarter, oldest first. Sep '23: Promoters 53.7%, DIIs 0.6%, Public 45.7%.Dec '23: Promoters 53.7%, DIIs 0.6%, Public 45.7%.Mar '24: Promoters 53.6%, DIIs 0.3%, Public 46.0%.Jun '24: Promoters 53.6%, DIIs 0.3%, Public 46.0%.Sep '24: Promoters 53.6%, DIIs 0.3%, Public 46.0%.Dec '24: Promoters 53.6%, DIIs 0.3%, Public 46.0%.Mar '25: Promoters 53.7%, DIIs 0.3%, Public 46.0%.Jun '25: Promoters 53.7%, DIIs 0.3%, Public 46.0%.Sep '25: Promoters 53.7%, DIIs 0.3%, Public 46.0%.Dec '25: Promoters 53.4%, DIIs 0.3%, Public 46.3%.Mar '26: Promoters 52.9%, DIIs 0.3%, Public 46.7%.Jun '26: Promoters 52.9%, DIIs 0.3%, Public 46.7%.
Who is on the register
Named in the Jun 2026 filing
Every holder of Brawn Biotech Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Brij Raj Gupta | 16.69% | unchanged |
| Investor Education And Protection Fund Author | 14.42% | unchanged |
| Shashi Bala Gupta | 8.27% | unchanged |
| Nitin Gupta | 6.45% | unchanged |
| Brij Bala Gupta | 6.30% | unchanged |
| Adarsh Kumar Gupta | 6.25% | unchanged |
| Atul Gupta | 2.36% | unchanged |
| A B Pharma P Ltd | 2.27% | unchanged |
| Kavita Gupta | 1.50% | unchanged |
| Daksha Kotak | 1.24% | unchanged |
| Bhawna Goyal | 0.99% | unchanged |
| Mamta Gupta | 0.44% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Learn to analyse Brawn Biotech Limited
Guides on how to read this kind of business and the numbers that matter.